BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gabriely G, Teplyuk NM, Krichevsky AM. Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy. 2011;7:1384-1386. [PMID: 21795860 DOI: 10.4161/auto.7.11.17371] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Mondal I, Sharma S, Kulshreshtha R. MicroRNA therapeutics in glioblastoma: Candidates and targeting strategies. AGO-Driven Non-Coding RNAs. Elsevier; 2019. pp. 261-92. [DOI: 10.1016/b978-0-12-815669-8.00010-5] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Teplyuk NM, Uhlmann EJ, Gabriely G, Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan A, Kraytsberg Y, Cialic R, Chiocca EA, Godlewski J, Tannous B, Krichevsky AM. Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic. EMBO Mol Med 2016;8:268-87. [PMID: 26881967 DOI: 10.15252/emmm.201505495] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 12.0] [Reference Citation Analysis]
3 El Fatimy R, Zhang Y, Deforzh E, Ramadas M, Saravanan H, Wei Z, Rabinovsky R, Teplyuk NM, Uhlmann EJ, Krichevsky AM. A nuclear function for an oncogenic microRNA as a modulator of snRNA and splicing. Mol Cancer 2022;21:17. [PMID: 35033060 DOI: 10.1186/s12943-022-01494-z] [Reference Citation Analysis]
4 Xiong DD, Xu WQ, He RQ, Dang YW, Chen G, Luo DZ. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme. Oncol Rep 2019;41:2194-208. [PMID: 30816530 DOI: 10.3892/or.2019.7022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
5 Gozuacik D, Akkoc Y, Ozturk DG, Kocak M. Autophagy-Regulating microRNAs and Cancer. Front Oncol 2017;7:65. [PMID: 28459042 DOI: 10.3389/fonc.2017.00065] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 16.2] [Reference Citation Analysis]
6 Fkih M'hamed I, Privat M, Ponelle F, Penault-Llorca F, Kenani A, Bignon YJ. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers. Cell Oncol (Dordr) 2015;38:433-42. [PMID: 26392359 DOI: 10.1007/s13402-015-0239-3] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
7 Li B, Huang Q, Wei GH. The Role of HOX Transcription Factors in Cancer Predisposition and Progression. Cancers (Basel) 2019;11:E528. [PMID: 31013831 DOI: 10.3390/cancers11040528] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 13.3] [Reference Citation Analysis]
8 Liu Y, Li M, Zhang G, Pang Z. MicroRNA-10b overexpression promotes non-small cell lung cancer cell proliferation and invasion. Eur J Med Res 2013;18:41. [PMID: 24216130 DOI: 10.1186/2047-783X-18-41] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
9 Huang Q, Song Q, Zhong W, Chen Y, Liang L. MicroRNA-10b and the clinical outcomes of various cancers: A systematic review and meta-analysis. Clinica Chimica Acta 2017;474:14-22. [DOI: 10.1016/j.cca.2017.08.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
10 Bahreyni-toossi M, Dolat E, Khanbabaei H, Zafari N, Azimian H. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2019;816-818:111679. [DOI: 10.1016/j.mrfmmm.2019.111679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dávalos A, Chroni A. Antisense oligonucleotides, microRNAs, and antibodies. Handb Exp Pharmacol 2015;224:649-89. [PMID: 25523006 DOI: 10.1007/978-3-319-09665-0_22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Dorvel BR, Reddy B Jr, Go J, Duarte Guevara C, Salm E, Alam MA, Bashir R. Silicon nanowires with high-k hafnium oxide dielectrics for sensitive detection of small nucleic acid oligomers. ACS Nano 2012;6:6150-64. [PMID: 22695179 DOI: 10.1021/nn301495k] [Cited by in Crossref: 97] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
13 Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment. World J Clin Oncol 2014; 5(2): 48-60 [PMID: 24829851 DOI: 10.5306/wjco.v5.i2.48] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
14 Teplyuk NM, Uhlmann EJ, Wong AH, Karmali P, Basu M, Gabriely G, Jain A, Wang Y, Chiocca EA, Stephens R, Marcusson E, Yi M, Krichevsky AM. MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma. Oncotarget 2015;6:3770-83. [PMID: 25738367 DOI: 10.18632/oncotarget.3009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
15 Jasinski-Bergner S, Mandelboim O, Seliger B. The role of microRNAs in the control of innate immune response in cancer. J Natl Cancer Inst 2014;106:dju257. [PMID: 25217579 DOI: 10.1093/jnci/dju257] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 5.0] [Reference Citation Analysis]
16 Khordadmehr M, Shahbazi R, Ezzati H, Jigari-Asl F, Sadreddini S, Baradaran B. Key microRNAs in the biology of breast cancer; emerging evidence in the last decade. J Cell Physiol 2019;234:8316-26. [PMID: 30422324 DOI: 10.1002/jcp.27716] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
17 Guessous F, Alvarado-Velez M, Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J, Schiff D, Purow B, Abounader R. Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol 2013;112:153-63. [PMID: 23307328 DOI: 10.1007/s11060-013-1047-0] [Cited by in Crossref: 106] [Cited by in F6Publishing: 97] [Article Influence: 11.8] [Reference Citation Analysis]
18 van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ. Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 2015;17:21. [PMID: 25849621 DOI: 10.1186/s13058-015-0526-y] [Cited by in Crossref: 160] [Cited by in F6Publishing: 162] [Article Influence: 22.9] [Reference Citation Analysis]
19 Yang XJ, Si RH, Liang YH, Ma BQ, Jiang ZB, Wang B, Gao P. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway. World J Gastroenterol 2016; 22(15): 3978-3991 [PMID: 27099441 DOI: 10.3748/wjg.v22.i15.3978] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
20 Wang M, Qiu R, Gong Z, Zhao X, Wang T, Zhou L, Lu W, Shen B, Zhu W, Xu W. miR-188-5p emerges as an oncomiRNA to promote gastric cancer cell proliferation and migration via upregulation of SALL4. J Cell Biochem 2019;120:15027-37. [PMID: 31009138 DOI: 10.1002/jcb.28764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
21 He C, Chen ZY, Li Y, Yang ZQ, Zeng F, Cui Y, He Y, Chen JB, Chen HQ. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma. BMC Nephrol 2019;20:127. [PMID: 30975094 DOI: 10.1186/s12882-019-1322-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
22 Li W, Li C, Xiong Q, Tian X, Ru Q. MicroRNA-10b-5p downregulation inhibits the invasion of glioma cells via modulating homeobox B3 expression. Exp Ther Med 2019;17:4577-85. [PMID: 31105788 DOI: 10.3892/etm.2019.7506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
23 Tang B, Li N, Gu J, Zhuang Y, Li Q, Wang HG, Fang Y, Yu B, Zhang JY, Xie QH. Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori. Autophagy. 2012;8:1045-1057. [PMID: 22647547 DOI: 10.4161/auto.20159] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 8.7] [Reference Citation Analysis]
24 Tang J, Ahmad A, Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 2012;13:13414-37. [PMID: 23202960 DOI: 10.3390/ijms131013414] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 10.6] [Reference Citation Analysis]
25 Aredia F, Scovassi AI. Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance. Future Med Chem. 2013;5:1009-1021. [PMID: 23734684 DOI: 10.4155/fmc.13.85] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
26 Saikia M, Paul S, Chakraborty S. Role of microRNA in forming breast carcinoma. Life Sciences 2020;259:118256. [DOI: 10.1016/j.lfs.2020.118256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Lu Y, Yao J, Yu J, Wei Q, Cao X. The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis. Sci Rep 2014;4:7498. [PMID: 25510966 DOI: 10.1038/srep07498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
28 Bi B, Li F, Guo J, Li C, Jing R, Lv X, Chen X, Wang F, Azadzoi KM, Wang L, Liu Y, Yang JH. Label-free quantitative proteomics unravels the importance of RNA processing in glioma malignancy. Neuroscience 2017;351:84-95. [PMID: 28341197 DOI: 10.1016/j.neuroscience.2017.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
29 Wolter JM, Kotagama K, Pierre-Bez AC, Firago M, Mangone M. 3'LIFE: a functional assay to detect miRNA targets in high-throughput. Nucleic Acids Res 2014;42:e132. [PMID: 25074381 DOI: 10.1093/nar/gku626] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
30 Palumbo S, Miracco C, Pirtoli L, Comincini S. Emerging Roles of microRNA in Modulating Cell-Death Processes in Malignant Glioma. J Cell Physiol. 2014;229:277-286. [PMID: 23929496 DOI: 10.1002/jcp.24446] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
31 Sjögren RJ, Egan B, Katayama M, Zierath JR, Krook A. Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells. Physiol Genomics 2015;47:45-57. [PMID: 25547110 DOI: 10.1152/physiolgenomics.00037.2014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
32 Wang YY, Li L, Ye ZY, Zhao ZS, Yan ZL. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. World J Surg Oncol 2015;13:259. [PMID: 26311318 DOI: 10.1186/s12957-015-0673-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
33 Avellino R, Carrella S, Pirozzi M, Risolino M, Salierno FG, Franco P, Stoppelli P, Verde P, Banfi S, Conte I. miR-204 targeting of Ankrd13A controls both mesenchymal neural crest and lens cell migration. PLoS One 2013;8:e61099. [PMID: 23620728 DOI: 10.1371/journal.pone.0061099] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
34 Sonntag KC, Woo TU, Krichevsky AM. Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. Exp Neurol 2012;235:427-35. [PMID: 22178324 DOI: 10.1016/j.expneurol.2011.11.035] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
35 Dávalos A, Fernández-Hernando C. From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. Pharmacol Res 2013;75:60-72. [PMID: 23435093 DOI: 10.1016/j.phrs.2013.02.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
36 Fritz HKM, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma. Eur J Cancer 2014;50:1758-65. [PMID: 24793999 DOI: 10.1016/j.ejca.2014.03.281] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
37 Yigit MV, Ghosh SK, Kumar M, Petkova V, Kavishwar A, Moore A, Medarova Z. Context-dependent differences in miR-10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 2013;32:1530-8. [PMID: 22580603 DOI: 10.1038/onc.2012.173] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 6.1] [Reference Citation Analysis]
38 Fantini S, Salsi V, Zappavigna V. HOX cluster-embedded micro-RNAs and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018;1869:230-47. [DOI: 10.1016/j.bbcan.2018.03.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
39 Ilhan-Mutlu A, Wöhrer A, Berghoff AS, Widhalm G, Marosi C, Wagner L, Preusser M. Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens. J Neurooncol 2013;112:347-54. [PMID: 23420397 DOI: 10.1007/s11060-013-1078-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
40 Li XL, Li SZ, Wu CX, Xing XH. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2. Kaohsiung J Med Sci 2021;37:294-304. [PMID: 33236530 DOI: 10.1002/kjm2.12323] [Reference Citation Analysis]
41 Krichevsky AM, Uhlmann EJ. Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. Neurotherapeutics 2019;16:319-47. [PMID: 30644073 DOI: 10.1007/s13311-018-00702-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
42 Kouri FM, Ritner C, Stegh AH. miRNA-182 and the regulation of the glioblastoma phenotype - toward miRNA-based precision therapeutics. Cell Cycle 2015;14:3794-800. [PMID: 26506113 DOI: 10.1080/15384101.2015.1093711] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
43 Li Q, Liu J, Meng X, Pang R, Li J. MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer. J Biol Res (Thessalon) 2017;24:10. [PMID: 28795052 DOI: 10.1186/s40709-017-0067-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
44 Schneider C, Kässens N, Greve B, Hassan H, Schüring AN, Starzinski-Powitz A, Kiesel L, Seidler DG, Götte M. Targeting of syndecan-1 by micro-ribonucleic acid miR-10b modulates invasiveness of endometriotic cells via dysregulation of the proteolytic milieu and interleukin-6 secretion. Fertil Steril 2013;99:871-881.e1. [PMID: 23206733 DOI: 10.1016/j.fertnstert.2012.10.051] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]